Biobizkaia
Centro de investigación
Universidad de Córdoba
Córdoba, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Córdoba (51)
2024
-
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
Journal of medical economics, Vol. 27, Núm. 1, pp. 109-125
-
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
Rheumatology (United Kingdom), Vol. 63, Núm. 3, pp. 772-779
-
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
Cell Reports, Vol. 43, Núm. 3
-
The evolutionary conserved miR-137/325 tandem mediates obesity-induced hypogonadism and metabolic comorbidities by repressing hypothalamic kisspeptin
Metabolism: Clinical and Experimental
2023
-
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae
American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034
-
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice
Transplantation, Vol. 107, Núm. 3, pp. 762-773
2022
-
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
American Journal of Transplantation, Vol. 22, Núm. 6, pp. 1671-1682
-
Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma
Cancers, Vol. 14, Núm. 23
-
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Frontiers in Cellular and Infection Microbiology, Vol. 12
-
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
Frontiers in Immunology, Vol. 13
-
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Breast, Vol. 66, pp. 77-84
2021
-
Antiphospholipid antibody profile stability over time: Prospective results from the APS ACTION clinical database and repository
Journal of Rheumatology, Vol. 48, Núm. 4, pp. 541-547
-
Changes in the Objective Structured Clinical Examination (OSCE) of University Schools of Medicine during COVID-19. Experience with a computer-based case simulation OSCE (CCS-OSCE)
Revista Clinica Espanola, Vol. 221, Núm. 8, pp. 456-463
-
Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
Advances in Rheumatology, Vol. 61, Núm. 1
-
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
Frontiers in Medicine, Vol. 8
-
Evaluation of Vitek-MS™ and Microflex LT™ commercial systems for identification of Acinetobacter calcoaceticus–baumannii complex
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 1, pp. 9-13
-
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial
Stroke, Vol. 52, Núm. 11, pp. 3440-3449
-
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
Arthritis Research and Therapy, Vol. 23, Núm. 1
2020
-
H. pylori Eradication Treatment Causes Alterations in the Gut Microbiota and Blood Lipid Levels
Frontiers in Medicine, Vol. 7
2019
-
Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn’s disease patients: the Practicrohn study
Expert Review of Gastroenterology and Hepatology, Vol. 13, Núm. 8, pp. 807-813